Venus Concept Inc., a global medical aesthetic technology leader, has announced that it has received FDA 510(k) clearance to market and sell Venus Viva MD, a non-invasive device intended to be used by aesthetic-related physicians or dermatologists. It expands the company’s skin rejuvenation offerings beyond the Venus Viva and Venus Versa, which were introduced to the medical aesthetics market in 2015 and 2016, respectively.
Read more at Globe Newswire >>